Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Passon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biotechnology Advances|February 10, 2023
Principles of antibodies with ultralong complementarity-determining regions and picobodiesMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
Journal of Pharmaceutical Sciences|December 25, 2025
A pharmaceutical developability perspective on antibodies with ultra-long CDRsMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
Plos Genetics|January 19, 2021
Human genome diversity data reveal that L564P is the predominant TPC2 variant and a prerequisite for the blond hair associated M484L gain-of-function effectJulia Böck, Einar Krogsaeter, Marcel Passon, et al.
Communications Biology|April 19, 2025
Stability convergence in natural antibodies with ultra-long hypervariable loopsMarcel Passon, Matja Zalar, Thomas Nehls, et al.
EMBO Molecular Medicine|August 5, 2022
TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann-Pick type C1, and Batten diseaseAnna Scotto Rosato, Einar K Krogsaeter, Dawid Jaślan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biotechnology Advances|February 10, 2023
Principles of antibodies with ultralong complementarity-determining regions and picobodiesMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
Journal of Pharmaceutical Sciences|December 25, 2025
A pharmaceutical developability perspective on antibodies with ultra-long CDRsMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
Plos Genetics|January 19, 2021
Human genome diversity data reveal that L564P is the predominant TPC2 variant and a prerequisite for the blond hair associated M484L gain-of-function effectJulia Böck, Einar Krogsaeter, Marcel Passon, et al.
Communications Biology|April 19, 2025
Stability convergence in natural antibodies with ultra-long hypervariable loopsMarcel Passon, Matja Zalar, Thomas Nehls, et al.
EMBO Molecular Medicine|August 5, 2022
TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann-Pick type C1, and Batten diseaseAnna Scotto Rosato, Einar K Krogsaeter, Dawid Jaślan, et al.
Pageof 1